Author:
Liu Wei,Okochi Hideaki,Benet Leslie Z.,Zhai Suo-Di
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference23 articles.
1. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–20.
2. Research CfDEa,U.S. Food and Drug Administration, Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, 2000 August, http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm064964.htm . (Available from)
3. Use CfMPfH,European Medicines Agency, Guideline on the investigation of bioequivalence, 2010 January 20, http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500070039 . (Available from)
4. Chen M-L, Amidon GL, Benet LZ, Lennernäs H, Yu LX. The BCS, BDDCS, and regulatory guidances. Pharm Res. 2011;28:1774–8.
5. Wu C-Y, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res. 2005;22:11–23.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献